This information was published on 2026-03-06T10:18:35 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2516094 (IR 1834665) |
| (220) |
18 Dec 2024
|
| (300) |
US, 18 Oct 2024, 98809316
|
| (500) |
Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.
|
| (511) (510) |
Class 5
Pharmaceutical preparations for treating muscle diseases or disorders; pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparations for treating metabolic diseases or disorders; pharmaceutical preparations for treating central nervous system diseases or disorders. |
| (540) | EMZILFOR |
| (550) | Word |
| (730) |
Dyne Therapeutics, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.